BridgeMD
New treatment option for Arterial Ischemic Stroke
Official title Early Doppler-Assisted Mobilization in Adults After Acute Ischemic Stroke
ClinicalTrials.gov ID: NCT07232498
What this study is testing
- What it's testing
- Post-stroke mobilization remains a subject of ongoing debate. While early mobilization-particularly the first out-of-bed mobilization-has been associated with reduced systemic complications and earlier rehabilitation, it also carries potential risks, such as neurological deterioration in the presence of hemodynamic instability.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients diagnosed with ischemic stroke aged 18 years or older;
- Ability to undergo carotid and transcranial Doppler ultrasound, as well as to mobilize within 48 hours;
- Informed consent obtained from the patient or legal representative.
You likely can't join if
- Pre-existing disability with a modified Rankin Scale (mRS) score ≥ 4;
- Diagnosis of Transient Ischemic Attack (TIA);
- Severe hemodynamic instability, defined as:
- Systolic blood pressure \ 220 mmHg;
- Peripheral oxygen saturation \< 92%;
- Heart rate \ 112 beats per minute;
See the full eligibility criteria
- Patients diagnosed with ischemic stroke aged 18 years or older;
- Ability to undergo carotid and transcranial Doppler ultrasound, as well as to mobilize within 48 hours;
- Informed consent obtained from the patient or legal representative.
- Pre-existing disability with a modified Rankin Scale (mRS) score ≥ 4;
- Diagnosis of Transient Ischemic Attack (TIA);
- Severe hemodynamic instability, defined as:
- Systolic blood pressure \ 220 mmHg;
- Peripheral oxygen saturation \< 92%;
- Heart rate \ 112 beats per minute;
- Body temperature \> 38.5°C;
- Neurological deterioration with altered level of consciousness (defined as Glasgow Coma Scale \< 10);
- Patients who underwent neurosurgical intervention within the past 30 days;
- Concomitant diagnosis of a rapidly progressive fatal disease (e.g., terminal-stage cancer);
- Requirement for continuous monitoring or continuous intravenous drug infusion;
- Acute deep vein thrombosis/pulmonary embolism.
The study team makes the final eligibility decision.
Where it's taking place
- Coimbra, Coimbra District, Portugal
- Lisbon, Lisbon District, Portugal
- Porto, Porto District, Portugal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Coimbra, Coimbra District, Portugal; Lisbon, Lisbon District, Portugal; Porto, Porto District, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.